These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 24514874

  • 1. In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.
    Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Hodges J, Harada R, Yates P, Piguet O, Pejoska S, Doré V, Yanai K, Masters CL, Kudo Y, Rowe CC, Okamura N.
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):816-26. PubMed ID: 24514874
    [Abstract] [Full Text] [Related]

  • 2. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Harada R, Yates P, Pejoska S, Kudo Y, Masters CL, Yanai K, Rowe CC, Villemagne VL.
    Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
    [Abstract] [Full Text] [Related]

  • 3. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF, Hanseeuw B, Schultz AP, Vannini P, Aghjayan SL, Properzi MJ, Jackson JD, Mormino EC, Rentz DM, Sperling RA, Johnson KA, Amariglio RE.
    JAMA Neurol; 2017 Dec 01; 74(12):1455-1463. PubMed ID: 28973551
    [Abstract] [Full Text] [Related]

  • 4. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD.
    Brain; 2016 May 01; 139(Pt 5):1551-67. PubMed ID: 26962052
    [Abstract] [Full Text] [Related]

  • 5. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL, Ahlskog JE, Tosakulwong N, Senjem ML, Spychalla AJ, Petersen RC, Jack CR, Lowe VJ, Josephs KA.
    Parkinsonism Relat Disord; 2018 Mar 01; 48():3-9. PubMed ID: 29254665
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
    Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E, Leuzy A, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G, Nordberg A.
    Mol Psychiatry; 2018 Jul 01; 23(7):1666-1673. PubMed ID: 28507319
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic Accuracy of Amyloid versus 18 F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed Dementia.
    Lesman-Segev OH, La Joie R, Iaccarino L, Lobach I, Rosen HJ, Seo SW, Janabi M, Baker SL, Edwards L, Pham J, Olichney J, Boxer A, Huang E, Gorno-Tempini M, DeCarli C, Hepker M, Hwang JL, Miller BL, Spina S, Grinberg LT, Seeley WW, Jagust WJ, Rabinovici GD.
    Ann Neurol; 2021 Feb 01; 89(2):389-401. PubMed ID: 33219525
    [Abstract] [Full Text] [Related]

  • 8. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.
    Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Jonasson M, Eriksson J, Lubberink M, Almkvist O, Wall A, Antoni G, Nordberg A.
    Eur J Nucl Med Mol Imaging; 2016 Aug 01; 43(9):1686-99. PubMed ID: 26996778
    [Abstract] [Full Text] [Related]

  • 9. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
    Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST.
    Brain; 2008 Jun 01; 131(Pt 6):1630-45. PubMed ID: 18339640
    [Abstract] [Full Text] [Related]

  • 10. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
    Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini ML, Miller ZA, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD.
    Brain; 2017 Dec 01; 140(12):3286-3300. PubMed ID: 29053874
    [Abstract] [Full Text] [Related]

  • 11. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ, Devous MD, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC, Xiong H, Joshi AD, Siderowf A, Mintun MA, 18F-AV-1451-A05 investigators.
    Brain; 2017 Mar 01; 140(3):748-763. PubMed ID: 28077397
    [Abstract] [Full Text] [Related]

  • 12. Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB.
    Ito H, Shinotoh H, Shimada H, Miyoshi M, Yanai K, Okamura N, Takano H, Takahashi H, Arakawa R, Kodaka F, Ono M, Eguchi Y, Higuchi M, Fukumura T, Suhara T.
    Eur J Nucl Med Mol Imaging; 2014 Apr 01; 41(4):745-54. PubMed ID: 24233004
    [Abstract] [Full Text] [Related]

  • 13. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease.
    Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, Rosen HJ, Schonhaut DR, Jagust WJ, Rabinovici GD.
    Neuroimage Clin; 2018 Apr 01; 17():452-464. PubMed ID: 29159058
    [Abstract] [Full Text] [Related]

  • 14. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM, Laymon CM, Cohen AD, Zhang Z, Price JC, Boudhar S, McDade E, Aizenstein HJ, Klunk WE, Mathis CA.
    Neuroimage Clin; 2015 Apr 01; 9():592-8. PubMed ID: 26640770
    [Abstract] [Full Text] [Related]

  • 15. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.
    Fodero-Tavoletti MT, Okamura N, Furumoto S, Mulligan RS, Connor AR, McLean CA, Cao D, Rigopoulos A, Cartwright GA, O'Keefe G, Gong S, Adlard PA, Barnham KJ, Rowe CC, Masters CL, Kudo Y, Cappai R, Yanai K, Villemagne VL.
    Brain; 2011 Apr 01; 134(Pt 4):1089-100. PubMed ID: 21436112
    [Abstract] [Full Text] [Related]

  • 16. 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes.
    Tsai RM, Bejanin A, Lesman-Segev O, LaJoie R, Visani A, Bourakova V, O'Neil JP, Janabi M, Baker S, Lee SE, Perry DC, Bajorek L, Karydas A, Spina S, Grinberg LT, Seeley WW, Ramos EM, Coppola G, Gorno-Tempini ML, Miller BL, Rosen HJ, Jagust W, Boxer AL, Rabinovici GD.
    Alzheimers Res Ther; 2019 Jan 31; 11(1):13. PubMed ID: 30704514
    [Abstract] [Full Text] [Related]

  • 17. [18F]-AV-1451 tau PET imaging in Alzheimer's disease and suspected non-AD tauopathies using a late acquisition time window.
    Lagarde J, Olivieri P, Caillé F, Gervais P, Baron JC, Bottlaender M, Sarazin M.
    J Neurol; 2019 Dec 31; 266(12):3087-3097. PubMed ID: 31535269
    [Abstract] [Full Text] [Related]

  • 18. Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia.
    Rowe CC, Pejoska S, Mulligan RS, Jones G, Chan JG, Svensson S, Cselényi Z, Masters CL, Villemagne VL.
    J Nucl Med; 2013 Jun 31; 54(6):880-6. PubMed ID: 23575995
    [Abstract] [Full Text] [Related]

  • 19. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Jack CR, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC.
    Brain; 2008 Mar 31; 131(Pt 3):665-80. PubMed ID: 18263627
    [Abstract] [Full Text] [Related]

  • 20. In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317.
    Betthauser TJ, Lao PJ, Murali D, Barnhart TE, Furumoto S, Okamura N, Stone CK, Johnson SC, Christian BT.
    J Nucl Med; 2017 Jun 31; 58(6):996-1002. PubMed ID: 27856627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.